Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2876 | 2050 | 44.2 | 66% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 983 | 10088 | ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//JOURNAL OF ATTENTION DISORDERS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ADULT ADHD | Author keyword | 78 | 55% | 5% | 98 |
| 2 | ADHD | Author keyword | 77 | 12% | 30% | 621 |
| 3 | JOURNAL OF ATTENTION DISORDERS | Journal | 63 | 31% | 8% | 168 |
| 4 | ATTENTION DEFICIT HYPERACTIVITY DISORDER | Author keyword | 40 | 10% | 18% | 374 |
| 5 | PEDIAT PSYCHOPHARMACOL UNIT | Address | 25 | 29% | 4% | 72 |
| 6 | ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER | Author keyword | 25 | 58% | 1% | 28 |
| 7 | ADULT ADHD PROGRAM | Address | 15 | 71% | 1% | 12 |
| 8 | CLIN PROGRAM PEDIAT PSYCHOPHARMACOL | Address | 14 | 30% | 2% | 38 |
| 9 | WENDER UTAH RATING SCALE | Author keyword | 13 | 71% | 0% | 10 |
| 10 | EXPERTISE ADULT ADHD | Address | 11 | 78% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PSYCHIATRIC STATUS | 188 | 53% | 12% | 252 |
| 2 | DEFICIT HYPERACTIVITY DISORDER | 151 | 10% | 70% | 1427 |
| 3 | MEDICATION TREATED ADULTS | 67 | 87% | 2% | 33 |
| 4 | UTAH RATING SCALE | 62 | 51% | 4% | 88 |
| 5 | ADHD | 56 | 10% | 26% | 523 |
| 6 | RESIDUAL TYPE | 54 | 75% | 2% | 39 |
| 7 | ADULT ADHD | 53 | 44% | 4% | 92 |
| 8 | AGE DEPENDENT DECLINE | 38 | 46% | 3% | 63 |
| 9 | SUBTHRESHOLD DIAGNOSES | 35 | 72% | 1% | 28 |
| 10 | REPORT SCALE ASRS | 35 | 57% | 2% | 42 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF ATTENTION DISORDERS | 63 | 31% | 8% | 168 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis | 2009 | 241 | 46 | 52% |
| The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies | 2006 | 468 | 25 | 84% |
| Childhood Attention-Deficit/Hyperactivity Disorder and Future Substance Use Disorders: Comparative Meta-Analyses | 2011 | 81 | 46 | 61% |
| Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review | 2011 | 105 | 105 | 45% |
| European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD | 2010 | 93 | 245 | 52% |
| Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines | 2013 | 15 | 86 | 69% |
| Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial | 2011 | 22 | 6 | 100% |
| Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis | 2012 | 34 | 63 | 57% |
| Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies | 2013 | 15 | 63 | 62% |
| Do stimulants improve functioning in adults with ADHD? A review of the literature | 2013 | 10 | 24 | 79% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEDIAT PSYCHOPHARMACOL UNIT | 25 | 29% | 3.5% | 72 |
| 2 | ADULT ADHD PROGRAM | 15 | 71% | 0.6% | 12 |
| 3 | CLIN PROGRAM PEDIAT PSYCHOPHARMACOL | 14 | 30% | 1.9% | 38 |
| 4 | EXPERTISE ADULT ADHD | 11 | 78% | 0.3% | 7 |
| 5 | DUKE ADHD PROGRAM | 10 | 73% | 0.4% | 8 |
| 6 | CLIN PROGRAM PEDIAT PSYCHOPHARMACOL ADULT | 7 | 44% | 0.6% | 12 |
| 7 | GERICHTLICHE PSYCHOL PSYCHIAT | 7 | 57% | 0.4% | 8 |
| 8 | IGPUP | 6 | 100% | 0.2% | 4 |
| 9 | PSYCHOMED PROGRAMS | 5 | 60% | 0.3% | 6 |
| 10 | ADHD PROGRAM | 5 | 45% | 0.4% | 9 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000256993 | SLUGGISH COGNITIVE TEMPO//POSITIVE ILLUSORY BIAS//OPPOSITIONAL DEFIANT DISORDER |
| 2 | 0.0000256664 | ATTENTION DEFICIT HYPERACTIVITY DISORDER//METHYLPHENIDATE//ADHD |
| 3 | 0.0000233899 | POST PROGRAM PSYCHIAT MENTAL HLTH//ATTENT DEFICIT STUDY GRP GEDA//GRP OBES EATING DISORDERS GOTA |
| 4 | 0.0000166994 | ADHD//ATTENTION DEFICIT HYPERACTIVITY DISORDER//DELAY AVERSION |
| 5 | 0.0000118895 | DRD4//DAT1//DOPAMINE TRANSPORTER GENE |
| 6 | 0.0000100731 | RITALIN//METHYLPHENIDATE//METHYLPHENIDATE RITALIN |
| 7 | 0.0000071583 | PEDIATRIC BIPOLAR DISORDER//JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY//JOHNSON JOHNSON STUDY PEDIAT PSYCHOPATHOL |
| 8 | 0.0000062858 | PRESCRIPTION STIMULANTS//NONMEDICAL USE//MORAL ENHANCEMENT |
| 9 | 0.0000042166 | MULTIDIMENSIONAL FAMILY THERAPY//TREATMENT ADOLESCENT DRUG ABUSE//ADOLESCENT SUBSTANCE ABUSE |
| 10 | 0.0000039133 | PROMOT MENTAL HLTH JUVENILE JUSTICE//JUVENILE JUSTICE//PSYCHOLEGAL STUDIES PROGRAM |